Trials / Completed
CompletedNCT03946085
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)
Clinical Evaluation of a Micronized, Lipid-based Carotenoid Supplement in Eyes With Retinal Drusen
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Guardion Health Sciences, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate the clinical benefits in visual function from dietary supplementation of the Lumega-Z carotenoid liquid-supplement in participants with drusen and at risk of AMD. The effects of Lumega-Z supplementation will be compared to an active comparator, the AREDS2 multivitamin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lumega-Z | A specially-formulated carotenoid supplement formula that utilizes a micronized, lipid-based liquid form of delivery. |
| DIETARY_SUPPLEMENT | AREDS2 | A commercially-available multivitamin soft gel formula. |
Timeline
- Start date
- 2018-01-19
- Primary completion
- 2018-10-23
- Completion
- 2018-11-01
- First posted
- 2019-05-10
- Last updated
- 2019-05-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03946085. Inclusion in this directory is not an endorsement.